Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$82,639,267
-$17,308,656 QoQ
Shares Held
4,598,735
+0.1% QoQ
Ownership
4.35%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#4
of 323 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Jun 30, 2024CallValue
$331,800
CallShares
2,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. SRPT ranks #26 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in SRPT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,639,267 | 4,598,735 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $99,947,923 | 4,593,195 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,540,111 | 2,441,455 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $41,194,712 | 2,137,764 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $36,965,018 | 2,161,697 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $35,157,161 | 550,880 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,125,815 | 75,054 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $25,261,500 | 202,270 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $85,603,452 | 541,794 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $331,800 | 2,100 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $44,363,611 | 342,682 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,154,646 | 302,340 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $969,760 | 8,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $98,244,809 | 810,467 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $147,638,954 | 1,289,198 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $151,219,219 | 1,097,143 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $89,592,389 | 691,406 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $87,294,764 | 789,712 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,298,798 | 30,667 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,912,517 | 293,299 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $72,603,803 | 806,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,339,732 | 252,376 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,629,974 | 20,967 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,429,479 | 86,267 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||